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E-cadherin is a calcium-dependent cell–cell adhesion molecule,
which forms the key functional component of adherens junctions of
all epithelial cells. It interacts with E-cadherin molecules on adja-
cent epithelial cells forming an adhesive structure, which has been
likened to an intercellular zipper (Shapiro et al, 1995). It plays a key
role in the establishment and maintenance of intercellular adhesion,
cell polarity and tissue architecture (Takeichi, 1991). Translation of
intercellular contact signals into cellular organization is thought to
be mediated by the catenins, which are key regulatory molecules in
this mechanism. a-catenin (102 kDa), b-catenin (94 kDa) and g-
catenin (82 kDa), are membrane undercoat proteins which, through
a series of interactions, link the cytoplasmic carboxy-terminal tail
of E-cadherin to the actin cytoskeleton (Nagafuchi and Takeichi,
1989).
a-catenin is homologous to Vinculin, a protein localized to
focal contacts and adherens junctions, and known to play a role in
linking these junctions to the actin cytoskeleton (Geiger et al,
1980).  b-catenin shows homology to the product of the Drosophila
segment polarity gene armadillo, and is an important component
of the Wingless-Wnt signalling cascade (Gumbiner, 1995; Peifer,
1995). Its role in signal transduction is independent of its adhesive
function or role in transcriptional regulation (Behrens et al, 1996).
b-catenin also interacts with the epidermal growth factor receptor
(EGFR) (Hoschuetzky, 1994), and the proto-ongcogene c-erbB2
(Ochiai et al, 1994), both members of the type I growth factor
receptor family, which have intrinsic tyrosine kinase activity. Both
EGFR and c-erbB2 genes are amplified in a number of tumours,
including gastric cancer (Lemoine et al, 1991). Phosphorylation of
b-catenin, possibly through interaction with EGFR and c-erbB2, is
thought to induce a disassembly of the E-cadherin–catenin
complex from the actin filament network thus disruption of cell
adhesion and may in turn potentiate the neoplastic process
(Shibamoto et al, 1994).
The demonstration of an APC–b-catenin interaction raised
much speculation as to the role of APC in regulating signal trans-
duction through the b-catenin interaction with the cytoskeleton,
thereby regulating some aspect of cell adhesion or cell growth
(Rubinfeld et al, 1993; Su et al, 1993). APC has been shown to be
important in regulating cytoplasmic b-catenin levels (Munemitsu
et al, 1995). The APC–b-catenin complex is translocated into the
nucleus where it interacts with the nuclear transcription factors
LEF-1 and hTcf-4 (Korinek et al, 1997), resulting in transcrip-
tional activation. Truncation of the carboxy-terminal domain of
the wild-type APC protein, in tumours containing APC gene
mutations (Munemitsu et al, 1995) results in accumulation of
cytoplasmic b-catenin, which is thought to contribute to the
inappropriate activation of target genes by the b-catenin–LEF–
TCF complex.
g-catenin bears homology to b-catenin and is identical to
desmosomal plakoglobin. p120ctn is the most recently discovered
member of the catenin family. It is phosphorylated by pp60v-src, a
tyrosine kinase known to be associated with the adherens junction
(Volberg et al, 1992), and which induces disruption of adherens
junctions and epithelial cell transformation when overexpressed.
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p120ctn is also tyrosine phosphorylated in response to stimulation
by mitogenic stimuli, including epidermal growth factor (EGF)
and colony-stimulating factor 1 (CSF1; Downing and Reynolds,
1991). These observations have suggested a role for p120ctn in cell
transformation and ligand-induced signalling. The existence of
multiple p120ctn isoforms is thought to represent a means for
modulating E-cadherin function, by selective expression (Staddon
et al, 1995).
A number of lines of evidence have implicated E-cadherin as a
tumour suppressor. Deletions or mutations of E-cadherin result in
disruption of adherens junction function and loss of calcium-
dependent cell–cell adhesion (Nagafuchi and Takeichi, 1988). The
chromosome 16q region and containing the E-cadherin gene is
affected by loss of heterozygosity in breast and prostate cancers
(Sato et al, 1990; Bergerheim et al, 1991; Carter et al, 1991).
Functional disturbance of the adherens junction may, however,
also result from defects of catenin structure and function (Hirano
et al, 1992; Kawanishi et al, 1995). In vivo studies have demon-
strated reduced immunoreactivity of E-cadherin, a- and b-catenin
in a wide variety of tumours (Shiozaki et al, 1991, 1994),
including breast (Oka et al, 1993), gastric (Shimoyama and
Hirohashi, 1991), (Matsuura et al, 1992; Becker et al, 1993, 1994),
colorectal (Nigam et al, 1993), pancreatic (Pignatelli et al, 1994)
and urogenital cancers (Umbas et al, 1992). An inverse relation-
ship to tumour grade and stage was noted (Oka et al, 1993;
Pignatelli et al, 1994) and in some cases a correlation with reduced
survival (Umbas et al, 1992; Bringuier et al, 1993; Jawhari et al,
1997).
Transformation from a normal epithelial cell to a malignant cell
is thought to be a multistep process and results from accumulation
of multiple gene abnormalities. A number of genetic and
chromosomal defects have been described in gastric carcinoma,
but no unifying hypothesis for the development of this tumour has
emerged (Tahara, 1995). Somatic E-cadherin mutations have been
described in up to 50% of diffuse-type gastric tumours and 14% of
mixed type tumours, but not intestinal tumours (Becker et al,
1993). A recent study reported a germline E-cadherin mutation
leading to a truncated gene product, responsible for early onset,
poorly differentiated gastric cancer in a large kindred from New
Zealand (Guilford et al, 1998). Inactivating E-cadherin mutations
were also identified in other gastric cancer families as well as
somatic mutations in a number of sporadic gastric cancers,
suggesting an important role for E-cadherin in the pathogenesis of
gastric cancer.
To elucidate the role of the E-cadherin–catenin complex in
gastric carcinoma, we examined expression and function of
complex components in a panel of gastric carcinoma cell lines.
Our results demonstrate evidence of aberrant expression and func-
tion of this complex in four of these cell lines.
MATERIALS AND METHODS
Cell lines
Kato 3, AGS, HT29 and MDCK, were obtained from the European
tissue culture collection. MKN7 and MKN45 were obtained from
Riken Cell Bank, Ibaraki, Japan, by kind permission of the origi-
nator, Dr Teiichi Motoyama. HSC39 and HSC40a were kindly
donated by the originator, Dr Kazuyoshi Yangihara.
Kato III is a cell line derived from a metastatic pleural effusion
secondary to signet ring carcinoma of the stomach. MKN45 is
derived from a moderate to poorly differentiated intestinal type
gastric carcinoma, while MKN7 is derived from a well-differenti-
ated, intestinal-type gastric carcinoma. HSC39 was derived from
malignant ascites arising secondary to a signet ring carcinoma,
while HSC40a was established from the same original tumour
after xenotransplantation of ascitic tumour cells into an athymic
BALB/c nude mouse.
Growth and maintenance of cells
Cells lines were maintained in Dulbecco’s modified Eagle’s
medium (DMEM; Gibco BRL) supplemented with 10% heat inac-
tivated, mycoplasma screened fetal calf serum (Gibco). The cells
were cultured at 378C in a humidified atmosphere containing 10%
carbon dioxide. Cells were tested for mycoplasma at 3-monthly
intervals.
Antibodies
Mouse monoclonal IgG antibodies to E-cadherin, a-, b- and g-
catenin and p120ctn, were purchased from Affinity Research
Products Ltd, Exeter, UK. Two antibodies to the EGFR were used,
EGFR1 a mouse monoclonal antibody, and 12E a rabbit polyclonal
antibody, were kindly donated by Professor W Gullick (Imperial
Cancer Research Fund (ICRF), London) (Wilding et al, 1996). The
APC antibody, Ab28, was kindly donated by Sir Walter Bodmer
(ICRF) (Efstathiou et al, 1998).
Immunofluoresence staining of cultured cells
Cells were grown on multiwell slides (Hendley, Essex, UK), and
fixed in 50:50 mixture of methanol and acetone at 2 20 C for
20 min. Incubation with primary antibodies was performed
overnight at 48C. After washing in phosphate-buffered saline
(PBS), the slides were incubated with biotinylated species-
specific IgG for 30 min (Dako Ltd, High Wycombe, UK). After
further washes in PBS, the slides were incubated in fluorescence
isothiocyanate (FITC)-labelled avidin (Vector Laboratories,
Peterborough, UK) for 10 min. Slides were mounted in Vecta
shield (Vector Laboratories). For negative controls, primary
antibody was replaced with mouse IgG.
Cell aggregation assay
The assay was performed as described by Takeichi (1977) with
modifications. Single cell suspensions were prepared by incuba-
tion in non-enzymatic dissociation media (Sigma-Aldrich
Company Ltd., Poole, UK) for 10 min at 378C. The dissociated
cells were washed twice in calcium- and magnesium-free medium
and suspended in either calcium- and magnesium-free medium, or
normal calcium containing medium at a concentration of 1 3 106
cell ml21. The cells were then transferred to 50-ml Falcon tubes,
preincubated with bovine serum albumin to reduce cells adhering
to the plastic. The cell suspension was incubated on a gyratory
shaker at 378C. The number of single cells were counted at time 0
and at 15 min intervals during the experiment using a size-gated
Coulter counter (Coulter Electronics, UK). Cell aggregation is
represented by the aggregation index, Nt/N0, which represents the
ratio of single particles at time t of incubation to the initial single
particle number at time 0. The aggregation index is plotted on the
y-axis against time on the x-axis.324 AU Jawhari et al
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Immunoprecipitation
Cell extracts were prepared by lysis on ice, with 0.5% Triton X-
100 buffer [50 mM sodium chloride (NaCl), 10 mM Pipes, 3 mol
magnesium chloride (MgCl2), 300 mM sucrose] with added
protease inhibitors, as described above. Preclearing of cell extracts
was performed using mouse IgG (2 mg ml21 of cell extract), to
reduce non-specific binding. Protein G sepharose beads (50 ml)
(Pharmacia Biotech, St Albans, UK) were prewashed in lysis
buffer, and incubated with cell extract in the presence of mouse
IgG (2 ml), for 1 h at 48C on a rotator. The slurry was then
centrifuged, and the cell extract transferred to a new tube
containing protein G (50 ml), prewashed and incubated in the pres-
ence of antibody (2 ml), for 2 h at 48C on a rotator. The samples
were sequentially washed with high stringency buffer (15 mM
Tris–HCl, 5 mM EDTA, 2.5 mM EGTA, 1% Triton X-100, 1%
sodium deoxycholate, 0.1% sodium dodecyl sulphate (SDS),
120 mM NaCl, 25 mM potassium chloride), high salt buffer (15 mM
Tris–HCl, 5 M EDTA, 2.5 mM EGTA, 1% Triton X-100, 1%
sodium deoxycholate, 1% SDS, 1 M NaCl) and low salt buffer
(15 mM Tris–HC1, 5 mM EDTA). Wash buffer was aspirated with a
needle and the precipitated proteins eluted from the beads under
reducing conditions by boiling in Laemmli sample buffer for
5 min. Composition of the eluted protein complexes was analysed
by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and
Western blotting. To confirm immunoprecipitation results and
ascertain that lysis and wash conditions did not influence reported
protein–protein interactions, cell lysis was also performed using
the milder NP-40 buffer (50 mM Tris pH 7.5, 100 mM NaCl, 0.5%
NP-40, 0.2 mM Na3VO4, 50 mM NaF). Protein G beads were
subsequently washed gently using this same buffer (data not
shown).
SDS-PAGE and Western blotting
Cell extracts were prepared using Laemmli sample buffer (715 mM
2-b-mercaptoethanol, 10% glycerol, 2% SDS, 40 mM Tris pH 6.8,
1m M EDTA; Laemmli, 1970), with a protease inhibitor cocktail
(aprotinin 0.1–2 mg ml21, leupeptin 0.5–2 mg ml21, PMSF 20–
100 mg ml21, trypsin-chymotrypsin inhibitor 10 mg ml21, TPCK
100 mg ml21 (all from Sigma-Aldrich Company Ltd, Poole, UK).
Sample protein concentration was determined by BioRad protein
assay (BioRad, Hemel Hempstead, UK), using spectrophotometry.
SDS-PAGE was performed under reducing conditions using an 8%
acrylamide resolving gel, pH 8.8, overlaid with a 4.5% stacking
gel pH 6.8. The separated proteins were transferred to nitrocellu-
lose (Millipore, UK), using BioRad apparatus. Visualization of
protein bands was achieved by incubation in primary antibody
overnight followed by extensive washing, and then in horseradish
peroxidase-labelled, secondary species-specific antibody (Dako
Ltd, High Wycombe, UK). The membrane was developed in ECL
chemiluminescent reagent (Amersham Life Science, Slough, UK)
and exposed to X-ray film.
RESULTS
Functional assessment of cadherin-mediated
intercellular adhesion in six gastric carcinoma cell lines
Cadherin function is reflected by the cell phenotype when grown
in culture and can be quantitatively measured using a cell–cell
aggregation assay. HT29 is a colon carcinoma cell line, which
forms a typical polygonal cell sheet in culture, characteristic of
epithelial cells. Previous characterization of the cadherin–catenin
complex in HT29 has established this to be intact. It was therefore
used as control.
Cell morphology and phenotype was assessed using phase
contrast microscopy, under standard cell culture conditions. Kato 3
cells grow as single cells or small cell aggregates floating in
suspension with a few scattered round cells adhering to the plastic.
HSC39 and HSC40a also grow in vitro as a suspension of single
cells or as loosely associated aggregates with no adherence to
plastic, while MKN45 grows as a loosely adherent monolayer with
spindle-shaped cells exhibiting poor cell–cell contact. MKN7 and
AGS both grow as flat coherent monolayers. Impaired cell–cell
adhesion was therefore apparent at phase contrast microscopy of
cells in culture, in four of the six gastric cell lines.
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Figure 1 Western blotting results for APC, E-cadherin, a-, b- and g-catenin
in five gastric carcinoma cell lines. The results of Western blotting for APC,
E-cadherin, a-, b- and g-catenin are shown. Each lane represents a different
cell line. Aberrant E-cadherin expression is seen in Kato 3, consistent with a
previously described mutation. AGS expressed very low levels of E-cadherin
and no a-catenin. A truncated b-catenin is seen in HSC39 and HSC40A, both
derived from the same tumour. g-Catenin is normally expressed in all cell
lines. A truncated APC protein product is seen in HT29 and no APC is
expressed by Kato 3Cell–cell adhesion in gastric carcinoma cell lines 325
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Functional assessment of calcium-dependent cell–cell adhesion
was performed using a cell–cell aggregation assay as described by
Takeichi et al (1997) with modifications. In the presence of a
normally functioning cadherin–catenin complex as seen in MDCK
and HT29 there was a progressive fall in the number of single cells
with time (65% at 1 h). This is demonstrated by a fall in aggrega-
tion index to 0.35 at 90 min in calcium-containing medium. The
aggregation index is calculated as the number of single cells at
time 3 number of single cells at time 0. Cadherin-dependent
cell–cell adhesion in HT29 is abolished by incubation of cells in
calcium-free media, with no change in the aggregation index
occurring with time. No calcium-dependent cell–cell aggregation
could be demonstrated, in any of the gastric carcinoma cell lines
suggesting impairment of E-cadherin-mediated intercellular
adhesion in these cell lines.
Expression of E-cadherin and the catenins in gastric
carcinoma cell lines
Aberrant expression of E-cadherin and/or catenins was demon-
strated in a number of the cell lines examined. Western blot
analysis (Figure 1) revealed very low levels of E-cadherin in AGS,
which were often barely discernible in repeat experiments.
Aberrant E-cadherin expression was detected in Kato 3 and
MKN45. Two protein bands reactive for E-cadherin were detected
in Kato 3, one at 120 kDa, and a second at a 130 kDa. MKN45
demonstrated one band at the expected molecular weight of
120 kDa and the second at 80 kDa, which is likely to represent the
extracellular tryptic product of E-cadherin as previously described
(Frixen et al, 1991). E-cadherin was detected at the expected
molecular weight of 120 kDa in HSC39, HSC40A and MKN7,
although levels of E-cadherin expression were lower in MKN7
compared to control (HT29) and other gastric carcinoma cell lines.
a-catenin expression was absent in AGS, but expressed at the
expected molecular weight of 102 kDa in the remaining five cell
lines, although levels were reduced in three of these cell lines,
Kato 3, HSC39 and HSC40A, compared to control. b-catenin
was truncated at 80 kDa in HSC39 and HSC40A, as previously
described by the originators (Kawanishi et al, 1995). Finally, all
six cell lines expressed g-catenin and p120ctn (data not shown) in
comparable amounts and at the expected molecular weight. A
band at 300 kDa immunoreactive for APC was detected in all but
one cell line, Kato 3, which was negative for APC, suggesting the
probable presence of a mutation of the APC gene. A truncated
APC protein migrating at 200 kDa was detected in HT29,
confirming a previously described mutation.
Cellular localization of E-cadherin and the catenins in
gastric carcinoma cell lines
Staining results are summarized in Table 1. Immunofluoresence
staining in the control cell line, HT29, revealed co-localization of
E-cadherin and the catenins at the cell membrane, with increased
staining intensity at points of cell–cell contact consistent with
adherens junctions. Diffuse cytoplasmic and nuclear staining was
additionally observed with b-catenin, reflecting its now known
role as transcriptonal regulator.
E-cadherin membranous staining was absent in AGS, and
patchy with low intensity in MKN7. These findings agree with
Western blotting data showing absent and reduced levels of E-
cadherin in these cell lines respectively. Linear membranous
staining was present, however, in the remaining four gastric carci-
noma cell lines, including Kato 3 and MKN45, which had aberrant
E-cadherin expression on Western blotting. Loss of membranous
staining for a-catenin was seen in Kato 3 and HSC39, HSC40a
and AGS. There was patchy membranous staining for b- and g-
catenin in Kato 3, while staining was cytoplasmic in HSC39,
HSC40a and AGS. p120ctn stained in a membranous distribution
in all cell lines. Loss of membranous localization of either
E-cadherin or the catenins, implies corresponding loss of their
adhesive function, though disruption of adherens junctions.
Staining for the EGFR revealed intense membranous distribu-
tion in Kato 3, and faint membranous staining with a punctate
pattern in MKN7 and MKN45. It was absent in AGS, HSC39 and
HSC40a.
Cell extract
antibody
protein G
Cell lysis
Boil to elute
proteins
SDS-PAGE and
Western blotting
Table 1 E-cadherin and catenin expression by immunofluoresence staining in gastric carcinoma cell lines
E-cadherin a-catenin b-catenin g-catenin p120ctn
Kato 3 Membranous Cytoplasmic Patchy Patchy Membranous
membranous membranous
AGS Negative Negative Cytoplasmic Cytoplasmic Membranous
MKN7 Membranous Patchy Membranous Membranous Membranous
membranous
MKN45 Membranous Membranous Membranous Membranous Membranous
HSC39 Membranous Cytoplasmic Cytoplasmic Cytoplasmic Membranous
HSC40a Membranous Cytoplasmic Cytoplasmic Cytoplasmic Membranous
Figure 2 Schematic representation of the examination of protein–protein
interactions through immunoprecipitation followed by Western blotting. Equal
aliquots of cell extract are each mixed with the immunoprecipitating antibody.
Immune complexes are formed consisting of the immunoprecipitating
antibody, its antigen and any other protein, which binds to primary antigen to
form a multimolecular complex. The immunoprecipitates are then captured
using protein G beads, which are washed, and the protein components of the
complexes eluted into suspension and then separated under reducing
conditions by SDS-PAGE and Western blotting. The presence of interacting
proteins can then be detected by probing the nitrocellulose blots with a panel
of antibodies to components of the cadherin–catenin complex326 AU Jawhari et al
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Protein interactions within the cadherin–catenin
complex in gastric carcinoma cell lines
We examined protein interactions within the cadherin–catenin
complex, using sequential immunoprecipitation and immuno-
blotting with E-cadherin, a-,  b-,  g-catenin, p120ctn, EGFR and
APC antibodies. The protein concentration of cell extracts was
measured by BioRad protein assay and equal aliquots were each
mixed with the immunoprecipitating antibody. Immune complexes
are formed consisting of the immunoprecipitating antibody, its
antigen and any other protein, which binds to primary antigen to
form a multimolecular complex. The immunoprecipitates are then
captured using protein G beads, which are washed, and the protein
components of the complexes eluted into suspension and then
separated under reducing conditions by SDS-PAGE and Western
blotting. The presence of interacting proteins can then be detected
by probing the nitrocellulose blots with a panel of antibodies to
components of the cadherin catenin complex (see diagramatic
representation, Figure 2).
HT29 was used to demonstrate the normal composition of the
cadherin–catenin complex (Figure 3). The figure consists of four
Western blots for E-cadherin, a-, b- and g-catenin performed on
HT29 cell extracts after immunoprecipitation with the antibody
shown above the panel. E-cadherin was co-immunoprecipitated
with b- and g-catenin and, to a lesser extent, with a-catenin anti-
bodies suggesting the presence of a binding interaction between
these proteins (top panel). a-catenin was precipitated with both b-
catenin and g-catenin (second panel), while both b and g-catenin
were immunoprecipitated in small quantities by EGFR antibodies.
These findings are in agreement with published data suggesting
that E-cadherin forms a complex with b- or g-catenin which in turn
bind to a-catenin (Ozawa and Kember, 1992). p120ctn has been
shown to bind directly to E-cadherin (Reynolds, 1994), although in
our hands, this interaction appeared to be highly sensitive to lysis
and wash conditions, and only demonstrable when using very mild
non-ionic conditions. EGFR has been shown to interact directly
with b- and g-catenin (Hoschuetzky et al, 1994). In each experi-
ment a negative control immunoprecipitation with non-immune
mouse IgG was performed.
Abnormalities of complex composition were demonstrated in a
number of gastric cell lines. Kato 3, which is known to have an E-
cadherin mutation, demonstrated significantly reduced binding of
E-cadherin to b-catenin compared to other cell lines (Figure 4, lane
5). Lane 3 represents the total amount of E-cadherin precipitated
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Figure 3 Western blotting of cell extracts after immunoprecipitation using
E-cadherin, catenin and EGFR antibodies in HT29. This Figure shows results
of sequential immunoprecipitation (I/P) of cell extracts, followed by Western
blotting to examine E-cadherin–catenin complex composition in HT29. Each
lane represents the results of immunoprecipitation with one antibody,
indicated above the panels. Precipitated proteins were separated by SDS-
PAGE and subjected to Western blotting using the antibody indicated to the
right of the diagram. E-cadherin was co-precipitated with b- and g-catenin,
and to a lesser extent with a-catenin antibodies (top panel, lanes 4–6).
a-Catenin is seen to bind to b-catenin and g-catenin (second panel, lanes
5–6), while both b- and g-catenin were immunoprecipitated in small quantities
by EGFR antibodies (bottom panel, lane 8). Lane 1 is a negative control I/P
with mouse IgG, while lane 2 is a positive control I/P using the same antibody
as the Western blot
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Figure 4 E-cadherin Western blots of gastric cell line extracts after
sequential immunoprecipitation with E-cadherin, catenin and EGFR
antibodies. Cell extracts indicated to the right were immunoprecipitated with
antibodies to E-cadherin, a- b- and g-catenin, p120ctn, and EGFR as indicated
above. Precipitated proteins were separated by SDS-PAGE and subjected to
Western blotting for the presence of E-cadherin in the immunoprecipitates.
E-cadherin binding to b-catenin was significantly reduced in Kato 3 (second
panel, lane 5) relative to the total amount of E-cadherin precipitated by
E-cadherin antibodies (lane 3), and no E-cadherin was detectable in g-
catenin immunoprecipitates in this cell line (second panel, lane 6). E-
cadherin binding to p120ctn could not be demonstrated in Kato 3, MKN7 and
MKN45 (lane 7). AGS fails to express E-cadherin, so as expected no
proteins could be demonstrated in the immunoprecipitates (panel 5). Lane 1
is a positive control I/P with b-catenin antibodies, while lane 2 is a negative
control I/P with mouse IgGCell–cell adhesion in gastric carcinoma cell lines 327
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by E-cadherin antibodies in a parallel experiment performed
simultaneously. In other words, only a small proportion of the total
amount of E-cadherin (lane 3), could be precipitated with b-
catenin antibodies (lane 5). This can be compared to the equal E-
cadherin band densities arising from immunoprecipitation with
E-cadherin or b-catenin antibodies in the other cell lines,
suggesting that the majority of the b-catenin in these cell lines is
E-cadherin bound. Equal amounts of cell extract protein, and
immunoprecipitating antibody were used in each experiment,
making a comparison of band density for a particular protein
between cell lines possible. AGS, which is negative for E-cadherin
on Western blotting, showed no E-cadherin protein on immuno-
precipitation with E-cadherin or catenin antibodies. E-cadherin
binding to p120ctn also appeared to be disrupted in Kato 3, MKN7
and MKN45 (Figure 4, lane7). E-cadherin was present in EGFR
immunoprecipitates in three cell lines, HT29, HSC39 and MKN7.
This is an unexpected finding and may represent an indirect inter-
action of E-cadherin with EGFR, through b-catenin, due to precip-
itation of higher order complexes.
b-catenin was immunoprecipitated by E-cadherin suggesting
preservation of the b-catenin–E-cadherin interaction antibodies
in all cell lines, except AGS, which fails to express E-cadherin
(Figure 5, lane 3). There was associated loss of a/b-catenin co-
precipitation in AGS suggesting loss of this interaction in the
absence of E-cadherin (Figure 5, lane 4, bottom panel). The trun-
cated b-catenin protein in HSC39 failed to co-precipitate with a-
catenin or EGFR, implying loss of the corresponding binding site
(Figure 5, lane 7 and 8, third panel). The b-catenin–EGFR interac-
tion was preserved in all other cell lines.
In some of our immunoprecipitation experiments separation of b-
catenin and g-catenin into two distinct complexes was apparently
not complete, with b-catenin and g-catenin appearing in the recip-
rocal immunoprecipitations (Figure 5, lane 6). In addition, b-catenin
was immunoprecipitated with p120ctn antibodies immunoprecipi-
tates (Figure 5, lane 7), and E-cadherin with EGFR (Figure 4, lane
8). These unexpected interactions may reflect co-immunoprecipita-
tion of a minor subpopulation of ‘higher order complexes’.
On immunoprecipitation with APC antibodies, b-catenin was
seen to be present in the immunoprecipitates in all cell lines apart
from Kato 3, which we have shown to have loss of APC expres-
sion (Figure 6). This suggests preservation of the APC–b-catenin
interaction in these cell lines even in the presence of a truncated b-
catenin protein as in HSC39.
DISCUSSION
Loss of cadherin-mediated intercellular adhesion is an important
contributory mechanism in tumour pathogenesis. It is postulated to
remove contact inhibition of proliferation, thus allowing escape
from growth control signals (St Croix et al, 1998). Loss of cadherin-
mediated adhesion may also act by potentiating tumour cell detach-
ment from the primary site, and resulting in dissemination of
malignant cells to form metastases at distant sites (Birchmeier et al,
1993). E-cadherin is thus postulated to act both as a growth
suppressor and invasion suppressor. An intact cadherin–catenin
complex is required, however, for maintenance of normal inter-
cellular adhesion, with mutations of either E-cadherin or a/b-
catenins being sufficient to disrupt adherens junction function.
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Western blot: b-catenin
Figure 6 b-catenin Western blot of gastric cell line extracts after
immunoprecipitation with APC antibodies. Cell extracts from six cell lines
indicated above the panel were immunoprecipitated with antibodies to APC
(Ab28). Precipitated proteins were separated by SDS-PAGE and subjected to
Western blotting for the presence of b-catenin in the immunoprecipitates.
b-Catenin was precipitated by APC antibodies in all cell lines except Kato 3,
which does not express APC protein (lane 4). Lane 1 is positive control
immunoprecipitation (I/P) with b-catenin antibody, while lane 2 is a negative
control I/P with mouse IgG
Figure 5 b-catenin Western blots of gastric cell line extracts after sequential
immunoprecipitation with E-cadherin, catenin and EGFR antibodies. Cell
extracts from six cell lines indicated to the right were immunoprecipitated with
antibodies to E-cadherin, a-, b- and g-catenin, p120cas and EGFR as
indicated above the panels. Precipitated proteins were separated by SDS-
PAGE and subjected to Western blotting for the presence of b-catenin in the
immunoprecipitates. b-Catenin was immunoprecipitated with E-cadherin in all
cell lines apart from AGS, which fails to express the E-cadherin protein (lane
5). The truncated b-catenin protein (80 kDa) in HSC39 fails to
immunoprecipitate with a-catenin or EGFR (third panel, lanes 4 and 8). Lane
1 is a negative control I/P using mouse IgG, while lane 2 is a positive control
I/P using b-catenin antibodies328 AU Jawhari et al
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In this study, examination of cell morphology, protein expres-
sion and localization, and molecular organization of the
cadherin–catenin complex in six gastric carcinoma cell lines have
demonstrated evidence of widespread dysfunction of calcium-
dependent intercellular adhesive mechanisms. E-cadherin is the
principal mediator of intercellular adhesion, and adherens junction
integrity in epithelial cells. When it functions normally, disruption
of other intercellular adhesion molecules has little effect on adhe-
sive function. Four of the six cell lines tested showed morpholog-
ical evidence of reduced intercellular adhesion, while all failed to
demonstrate any evidence of calcium-dependent intercellular
adhesion when examined in a cell–cell aggregation assay.
A variety of mutations in the cadherin–catenin system have previ-
ously been described in a number of these cell lines. We confirm
these defects, and additionally demonstrate loss of expression of
some components of the complex. By a detailed examination of
protein expression, cellular localization by immunocytochemisty,
and co-immunoprecipitation analysis to assess protein–protein
interactions within the cadherin–catenin complex, we have identi-
fied putative defects in the corresponding adhesion systems.
Kato III is known to have an E-cadherin point mutation,
resulting in the production of aberrant mRNA, which is manifested
by the presence of two E-cadherin bands on Western blotting, at
120 and 130 kDa (Oda et al, 1994). E-cadherin dysfunction in
Kato III secondary to mutation is demonstrable by its tendency to
grow as free-floating cells with little tendency towards calcium-
dependent cell–cell aggregation. Immunoprecipitation experi-
ments revealed reduced E-cadherin binding to b-catenin and no
binding to g-catenin, suggesting disruption of cadherin–catenin
complex integrity. These abnormalities were associated with
reduced intensity and heterogeneity of staining for the catenins at
cell borders. It seems likely that the E-cadherin mutation results
either in loss of the catenin-binding site or steric changes inter-
fering with binding to the catenins, and hence loss of catenin local-
ization to the adherens junction and interruption of the adherens
junction link to the actin cytoskeleton.
An E-cadherin mutation has also been described in MKN45
(Oda et al, 1994), in this case at the extracellular calcium-binding
domain. This would explain the loss of cell–cell aggregation
despite the continued normal expression of both E-cadherin and
catenins at the cell membrane and the normal protein interactions
with the catenins. The lower molecular weight band in the E-
cadherin blot thought to represent the extracellular tryptic product
of E-cadherin as previously described (Frixen et al, 1991).
MKN7 also demonstrated total loss of cell–cell aggregation
despite expression of all components of the cadherin–catenin
complex at the expected molecular weights and normal membra-
nous localization. E-cadherin levels were low compared to other
cell lines and to control, both on Western blotting and immuno-
cytochemical staining. On immunoprecipitation with E-cadherin
antibodies, the only aberration in protein interactions was failure
to demonstrate the expected binding of p120ctn to E-cadherin, the
significance of which is uncertain. The explanation for impaired
intercellular adhesion is less obvious in this cell line. A point
mutation in the E-cadherin, or catenin genes has not been
excluded.
HSC39 has previously been shown to have a b-catenin mutation
resulting in protein truncation with loss of the a-catenin-binding
site (Kawanishi et al, 1995). This is demonstrated by loss of the
E-cadherin–b-catenin interaction with a-catenin (Figure 5, lane 4,
panel 3), which in turn links it to the actin cytoskeleton.
Immunofluoresence staining demonstrated diffuse cytoplasmic
staining of the catenins with loss of membranous localization,
suggesting failure to associate with E-cadherin at the cell
membrane. These abnormalities in the cadherin–catenin complex
are reflected by loss of calcium-dependent cadherin-mediated
cell–cell adhesion, and by failure of cells to form a monolayer in
culture.
AGS showed failure of E-cadherin and a-catenin on Western
blotting and immunocytochemical staining. Loss of a-catenin
expression may be secondary to loss of E-cadherin. Previous data
have suggested that E-cadherin confers stability on a-catenin, in
the absence of which it is broken down in the cytoplasm. Normal
b-catenin expression was seen on Western blotting, but this was
totally cytoplasmic in distribution. This is not surprising as its
location at the cell membrane depends on binding to E-cadherin,
which in the case of AGS fails to be expressed.
p120ctn binds to the juxtamembranous region of the E-cadherin
cytoplasmic tail, which has been shown to support the lateral
clustering of E-cadherin molecules at the cell surface. p120ctn is
thought to act as an intermediary binding protein allowing cluster-
ing of E-cadherin at the cell surface, a function which allows
modulation of adhesive strength under different cirmumstances
(Yap et al, 1998). We found the E-cadherin–p120ctn interaction
to be highly sensitive to lysis and buffer conditions, with easy
disruption of the complex. The continued membranous localiza-
tion of p120ctn in all the cell lines, suggests maintenance of its
normal binding relationship with E-cadherin, as its membranous
localization depends on this relationship.
Apart from binding to E-cadherin at the cell membrane, a signifi-
cant proportion of the catenin pool is free cytoplasmic protein, or
exists in the form of cadherin-independent a/b-catenin, or a/g-
catenin complexes. These complexes are thought to influence the
titration of catenins between cadherin and APC complexes.
Mutagenesis studies have shown that for tumour formation to ensue,
truncation of the APC protein must include loss of that part of the
protein responsible for the ability to down-regulate b-catenin. The
resulting increase in cytoplasmic b-catenin levels, and the ensuing
increased translocation to the nucleus, results in autonomous
transcription of Tcf target genes, known to be specific to colonic
epithelium, and thus contributes to neoplastic transformation.
Mutations of the amino terminal regulatory domain of b-catenin
have been demonstrated in 48% of colorectal tumours lacking
APC mutations (Sparks et al, 1998). Mutations in this area of the
protein render it insensitive to APC-mediated degradation. b-
catenin mutations were also present in a similar proportion of
colorectal adenomas suggesting that like APC, these mutations
arise early in tumorigenesis. In an exciting recent discovery, one
of the cancer-promoting genes at the end of the b-catenin signal
transduction pathway has been shown to be the oncogene c-myc
(Sparks, et al, 1998). Wild-type APC is thought to prevent b-
catenin from forming a complex with Tcf-4 and activating c-myc
expression. But when APC is mutated, b-catenin accumulates and
is translocated to the nucleus where it results in sustained tran-
scriptional activation of certain genes, including c-myc, and causes
tumour growth. This is a rare example of loss of a tumour
suppressor gene resulting in activation of an oncogene. The APC
gene is mutated in up to 20% of gastric carcinomas and in a similar
proportion of gastric adenomas (Horii et al, 1992; Tamura et al,
1994). The data presented in this study demonstrate preservation
of the APC–b-catenin interaction in 5 gastric carcinoma cell lines
even in the presence of a truncated b-catenin protein as in HSC39.In conclusion, we have demonstrated frequent abnormalities of
expression and function of the cadherin–catenin complex, corre-
lated with evidence of impaired protein–protein interactions
within the cadherin–catenin complex. These abnormalities mani-
fest with disturbance of cadherin-mediated intercellular adhesion
in gastric carcinoma cell lines. While the defects demonstrated
were heterogeneous, affecting E-cadherin, a and b-catenin, the
functional result was similar, that of loss of cadherin-mediated
cell–cell adhesion. These findings support previously reported in
vivo findings of a role for inactivation of E-cadherin-mediated
intercellular adhesion in the pathogenesis and progression of
gastric carcinoma.
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